Risk adjusted net present value: What is the current valuation of Pfizer’s Osivelotor?
Osivelotor is a small molecule commercialized by Pfizer, with a leading Phase III program in Sickle Cell Disease.
Osivelotor is a small molecule commercialized by Pfizer, with a leading Phase III program in Sickle Cell Disease.
What's Your Reaction?
